Medtronic stock was down stock was down today after its third-quarter revenue slightly missed the Wall Street analyst consensus.

CEO Geoff Martha said Medtronic would submit its application for urological procedures to the Food and Drug Administration by ...

The massive robot-making, pacemaker-inventing medtech company Medtronic is facing a financial snag: the humble stapler.

The instructions for use have been updated to address issues that led to a greater risk of neurovascular events in an early ...

J&J said it found no immediate procedure-related causes from the atrial fibrillation therapy but that risks can escalate if a ...

Nearly six weeks after Johnson & Johnson paused the U.S. external evaluation of its Varipulse pulsed field ablation catheter ...